Obexelimab ( DrugBank: Obexelimab )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
300	IgG4関連疾患	1

300. IgG4関連疾患

臨床試験数 : 40 / 薬物数 : 47 - (DrugBank : 21) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 141

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05662241 (ClinicalTrials.gov)	September 30, 2022	14/12/2022	A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease	A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy ...	IgG4 Related Disease	Drug: Obexelimab;Other: Placebo	Zenas BioPharma (USA), LLC	NULL	Recruiting	18 Years	N/A	All	200	Phase 3	United States

First Previous1Next Last